Open-label, Multicenter, Randomized Study Investigating the Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Myofascial Pain Syndrome in the Neck and Shoulder Girdle

Abstract

ObjectivesTo evaluate two doses of botulinum toxin A [BoNT-A] for the treatment of chronic myofascial pain syndrome [MPS].MethodsA 12-week, open-label, randomized study in which patients [N = 163] with MPS in the neck and shoulder girdle muscles were treated with intramuscular injections of 200 U [25 U/trigger point [TrP]] or 320 U [40 U/TrP] BoNT-A.ResultsAt Week 7, 34.8 percent of BoNT-A 200 U and 34.3 percent of BoNT-A 320 U patients had clinically significant improvement in pain. Treatment was well-tolerated.ConclusionsBoth doses provided effective relief from chronic MPS; benefits were maintained for at least three months.